Eurofins reinforces its footprint in the US with the acquisition of QC Laboratories
05 May 2015
Eurofins Scientific (EUFI.PA), the world leader in food and environment testing, announces the acquisition of QC Laboratories (QCL), a leading full-service environment and food analytical testing provider, as well as a dairy testing reference laboratory, located 80 miles from Eurofins' flagship Lancaster campus.
Founded in 1943, QCL employs about 200 staff and generates annual revenues of about US$ 20m across its 2 laboratories in Pennsylvania. QCL offers a broad range of analytical services to support both commercial clients and government agencies to comply with major federal and state regulatory programs. QCL's food testing services include both microbiology and chemistry testing, with a strong reputation in the local market for dairy testing. In environmental testing, QCL's analytical competencies include the full spectrum of testing services for compliance with the US Environmental Protection Agency (EPA) programs.
QCL's competencies complement Eurofins' recognized capabilities and reinforce the Group's growing US footprint, especially on the East Coast. Its addition into the Eurofins network demonstrates the Group's commitment to expanding its presence and service offering in the US market. In return, QCL gains access to Eurofins' robust network capabilities and the latest technologies to further improve its service offering to its customers, thereby further increasing market share.
Comment from Dr. Gilles Martin, Eurofins CEO: "We are pleased to welcome QCL to the Eurofins Group. QCL's competencies and geographical focus are a good fit to Eurofins' food and environment testing footprint in the US. This acquisition is a further demonstration of Eurofins' commitment to build the best and widest-reaching analytical testing network in the market."
For more information about Eurofins, please visit www.eurofins.com or contact:
Eurofins Scientific Group
Phone: +32 2 766 1620
Notes for the editor:
Eurofins - a global leader in bio-analysis
Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.
With over 17,000 staff in more than 200 laboratories across 36 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
Important disclaimer: This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.